November 13, 2019

Bala Venkataraman
Chief Executive Officer
Amplitude Healthcare Acquisition Corporation
1177 Avenue of the Americas, Fl 40
New York, NY 10036

       Re: Amplitude Healthcare Acquisition Corporation
           Form S-1 filed October 25, 2019
           Amendment No. 1 to Form S-1 filed November 6, 2019
           Amendment No. 2 to Form S-1 filed November 8, 2019
           File No. 333-234324

Dear Mr. Venkataraman:

       We have reviewed your registration statement and have the following
comments. In
some of our comments, we may ask you to provide us with information so we may
better
understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comments apply to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to these comments, we may have additional comments.

Amendment No. 1 to Registration Statement on Form S-1

Exhibits

1.     We note that the form of warrant agreement filed as Exhibit 4.4 provides
that the company
       agrees that any action, proceeding or claim against it arising out of or
relating in any way
       to the agreement shall be brought and enforced in the courts of the
State of New York or
       the United States District Court for the Southern District of New York,
and irrevocably
       submits to such jurisdiction, "which jurisdiction shall be exclusive."
If this provision
       requires investors in this offering to bring any such action, proceeding
or claim in the
       courts of the State of New York or the United States District Court for
the Southern
       District of New York, please disclose such provision in your
registration statement, and
       disclose whether this provision applies to actions arising under the
Securities Act or
 Bala Venkataraman
Amplitude Healthcare Acquisition Corporation
November 13, 2019
Page 2
         Exchange Act. If the provision applies to actions arising under the
Securities Act or
         Exchange Act, please also add related risk factor disclosure. If this
provision does not
         apply to actions arising under the Securities Act or Exchange Act,
please also ensure that
         the provision in the warrant agreement states this clearly.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       You may contact Amy Geddes at 202-551-3304 or Doug Jones at 202-551-3309
if you
have questions regarding comments on the financial statements and related
matters. Please
contact Susan Block at 202-551-3210 or Laura Nicholson at 202-551-3584 with any
other
questions.



FirstName LastNameBala Venkataraman                  Sincerely,
Comapany NameAmplitude Healthcare Acquisition Corporation
                                                     Division of Corporation
Finance
November 13, 2019 Page 2                             Office of Trade & Services
FirstName LastName